Isolation and Identification of Acinetobacter baumanni from clinical samples and study sensitivity to antibiotics.

.M.hussein, Najeeb; A.  Abdul-Rahman, Ibrahim; Al Wahab B. Hussein, Abd

doi:10.37652/juaps.2015.124385

Document Type : Research Paper

Authors

¹ University of Anbar - College of Science

² University of Fallujah - College of Veterinary Medicine

10.37652/juaps.2015.124385

Abstract

In this study, two hundred clinical samples have been chosen to isolate Acinetobacter baumanni from patients whose suffering from different infections, which included swabs from sputum, urine, wounds and burns. VITEK 2 COMPACT system has been used to diagnose percentage of bacteria in the samples and the highest rate was wounds infection, urinary tract infection and burns infection and the percentage 20%, 10% and 6.6% respectively. Moreover, antibiotics sensitivity have been taken place and used diffusion method, most of isolates were sensitive to Amikacin, Ciprofloxacin, Gentamicin, Cefixime, Cefotaxime, Ceftriaxone, Trimethoprim, Cefalexine, Amoxicillin, Rifampicin. The results showed resistance some A baumannii isolates of bacteria to antibiotics Amoxicillin, Cefixime, Trimethoprim, Rifampicin, cefalexine, Amikacin, Ciprofloxacin, Ceftriaxone, Cefotaxime, Gentamicin which included IAN1, IAN4, IAN5, IAN6, IAN 10 and 100% .

Keywords

Acinetobacter baumannii

Main Subjects

Biology

References

Falagas, M. E., P. I. Rafailidis, D. K. Matthaiou, S. Virtzili, D. Nikita, and A. Michalopoulos. 2008. Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter genospecies 13 TU infections: Characteristics and outcome in a series of 28 patients. Int J Antimicrob Agents32:450-4.

2: Paterson, D. 2006. The epidemiological profile of infections with multidrug resistant Pseudomonas aeruginosa and Acinetobacter species. Clinicalinfectious diseases 43:S43-S48.

3: Giamarellou H., Antoniadou A. and Kanellakopoulou K. (2008). Acinetobacter baumannii: a universal threat to public health? Int J Antimicrob Agents, 32:106-19.

4: Fournier, P. E., and H. Richet. 2006. The epidemiology and control of Acinetobacter genospecies 13 TU in health care facilities. Clin Infect Dis42:692.

5: Karthikeyan, K., Thirunarayan, M.A., and Krishnan, P. 2010. Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. J. Antimicrob. Chemother. 65, 2253–2254.

6: Dallo, S.F. and Weitao, T. 2010. Insights into Acinetobacter warwound infections, biofilms, and control. Adv. Skin Wound Care23, 169–174.

7: D’Arezzo, S., Principe, L., Capone, A., Petrosillo, N., Petrucca, A., and Visca, P. 2011. Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy. J. Antimicrob. Chemother. 66, 54–61.

8: Corvec, S., N. Caroff, E. Espaze, C. Giraudeau, H. Drugeon, and A. Reynaud. 2003. AmpC cephalosporinase hyperproduction in Acinetobacter genospecies 13 TU clinical strains. J Antimicrob Chemother 52:629-35.

9: Hujer, K., N. Hamza, A. Hujer, F. Perez, M. Helfand, C. Bethel, J. Thomson, V. Anderson, M. Barlow, L. Rice, F. Tenover, and R. Bonomo. 2005. Identification of a new allelic variant of the Acinetobacter genospecies13 TU cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymes. Antimicrobial agents and chemotherapy 49:2941-2948.

10: Perez, F., A. Endimiani, K. M. Hujer, and R. A. Bonomo. 2007. The continuing challenge of ESBLs. Curr Opin Pharmacol 7:459-69.

11: Xia, J., et al. (2014). "A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam." International Journal of Infectious Diseases 23(0): 90-93.

12: Turton, J. F., N. Woodford, J. Glover, S. Yarde, M. E. Kaufmann, and T. L. Pitt. 2006. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol 44:2974-6.

13: Brown, S.. Young, H-K and Amyes, S. G. B.2005. Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin. Microbiol. Infect. 11:15-23.

Journal of University of Anbar for Pure Science

Isolation and Identification of Acinetobacter baumanni from clinical samples and study sensitivity to antibiotics.

References

References

Volume 9, Issue 1
April 2015
Page 76-81

Isolation and Identification of Acinetobacter baumanni from clinical samples and study sensitivity to antibiotics.

References

References

Volume 9, Issue 1April 2015Page 76-81

Volume 9, Issue 1
April 2015
Page 76-81